Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Riociguat
Merck Sharp & Dohme Ltd
C02KX05
Riociguat
1.5mg
Tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050100; GTIN: 5010605333125 5010605333071
PACKAGE LEAFLET: INFORMATION FOR THE USER ADEMPAS 0.5 MG FILM-COATED TABLETS ADEMPAS 1 MG FILM-COATED TABLETS ADEMPAS 1.5 MG FILM-COATED TABLETS ADEMPAS 2 MG FILM-COATED TABLETS ADEMPAS 2.5 MG FILM-COATED TABLETS Riociguat This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Adempas is and what it is used for 2. What you need to know before you take Adempas 3. How to take Adempas 4. Possible side effects 5. How to store Adempas 6. Contents of the pack and other information 1. WHAT ADEMPAS IS AND WHAT IT IS USED FOR Adempas contains the active substance riociguat. Riociguat is a type of medicine called a guanylate cyclase (sGC)-stimulator. It works by widening the pulmonary arteries (the blood vessels that connect the heart to the lungs), making it easier for the heart to pump blood through the lungs. Adempas can be used to treat adults with certain forms of pulmonary hypertension, a condition in which these blood vessels become narrowed, making it harder for the heart to pump blood through them and leading to high blood pressure in the vessels. Because the heart must work harder than normal, people with pulmonary hypertension feel tired, dizzy and short of breath. By widening the narrowed arteries, Adempas leads to an improvement in your ability to carry out physical activity. Read the complete document
OBJECT 1 ADEMPAS 0.5 MG FILM-COATED TABLETS Summary of Product Characteristics Updated 13-Mar-2018 | Merck Sharp & Dohme Limited This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. Name of the medicinal product Adempas® 0.5 mg film-coated tablets Adempas® 1 mg film-coated tablets Adempas® 1.5 mg film-coated tablets Adempas® 2 mg film-coated tablets Adempas® 2.5 mg film-coated tablets 2. Qualitative and quantitative composition Adempas 0.5 mg: Each film-coated tablet contains 0.5 mg of riociguat. Adempas 1 mg: Each film-coated tablet contains 1 mg of riociguat. Adempas 1.5 mg: Each film-coated tablet contains 1.5 mg of riociguat. Adempas 2 mg: Each film-coated tablet contains 2 mg of riociguat. Adempas 2.5 mg: Each film-coated tablet contains 2.5 mg of riociguat. Excipients with known effect: Each 0.5 mg film-coated tablet contains 37.8 mg lactose (as monohydrate), Each 1 mg film-coated tablet contains 37.2 mg lactose (as monohydrate), Each 1.5 mg film-coated tablet contains 36.8 mg lactose (as monohydrate), Each 2 mg film-coated tablet contains 36.3 mg lactose (as monohydrate), Each 2.5 mg film-coated tablet contains 35.8 mg lactose (as monohydrate). See section 4.4. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Adempas is a film-coated tablet. • _0.5 mg tablet_: white, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 0.5 and an “R” on the other side. • _1 mg tablet_: pale yellow, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1 and an “R” on the other side. • _1.5 mg tablet_: yellow-orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side and 1.5 and an “R” on the other side. • _2 mg tablet_: pale orange, round, biconvex tablets of 6 mm, marked with the Bayer cross on one side a Read the complete document